Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency. - Wikidata - wikimedia - TriplyDB

Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency.

Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency.

http://www.wikidata.org/entity/Q34801776

about

Advances of gene therapy for primary immunodeficiencies Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency.Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs.Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases.Gene therapy approaches for stem cell protection.Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.Prevention of accelerated presbycusis by bone marrow transplantation in senescence-accelerated mice.

P2860

Q26742031-449614AB-9ED9-40F2-AD9D-8773555D1260 Q34098712-1722045E-711B-4954-8418-62C0C4B7C953 Q34386311-29720029-BE93-4ACD-AA4B-A4AFD8ECBE46 Q34401676-4EF9949A-51BD-44CA-B885-F825D3FC463A Q36911194-4DCF2454-8925-49E1-BF8C-85015583F3A0 Q38268152-6845B6CC-D88A-42AB-A7E5-9BF705121070 Q50490179-EA2E5EAE-23BA-4967-9245-D9E66A435B26

P2860

Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency.

http://www.wikidata.org/entity/Q34801776

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Virus-specific immunity after ...... ere combined immunodeficiency.

@ast

Virus-specific immunity after ...... ere combined immunodeficiency.

@en

Virus-specific immunity after ...... ere combined immunodeficiency.

@nl

type

label

Virus-specific immunity after ...... ere combined immunodeficiency.

@ast

Virus-specific immunity after ...... ere combined immunodeficiency.

@en

Virus-specific immunity after ...... ere combined immunodeficiency.

@nl

prefLabel

Virus-specific immunity after ...... ere combined immunodeficiency.

@ast

Virus-specific immunity after ...... ere combined immunodeficiency.

@en

Virus-specific immunity after ...... ere combined immunodeficiency.

@nl

P1433

Q34801776-2DF45A4C-AD90-4A68-9FAA-C8D1510453E7

P1476

Q34801776-8C3854F5-D427-494F-92B6-393389DD68D1

P2093

Q34801776-815D6C3E-138C-4F10-9E9D-4E19C6F15FD3

Q34801776-890FBE1C-C029-4196-A7EB-BF82D6F7213E

Q34801776-A0EA7F5F-0EA0-41F5-A27B-EC8929F16724

Q34801776-E7155265-A05A-4D93-8AB0-C7ED14F15A90

P2860

Q34801776-018769CC-6C1A-4D85-909C-85B45BEB2710

Q34801776-0C13C1D6-F83F-4121-8C6B-A88E8AB5CF35

Q34801776-164D1D94-D227-4BEC-96F4-66B7C27AC5AC

Q34801776-184F149F-25A5-49DA-A588-597827F613D3

Q34801776-34C849A6-993A-4A1E-9D4D-E1354EFB52DB

Q34801776-43B8CAD3-06A5-4449-9CF5-6A99D3DE93AD

Q34801776-4FD2BB08-C6FD-4283-8C25-7CA91A55563E

Q34801776-522BD6FB-639B-4CB6-9BA3-EE131B47A9ED

Q34801776-5A062F00-6F4B-4BA6-95AA-B1469DD864E0

Q34801776-5C6CD831-F838-4C08-9D5F-099CA5AECADD

P304

Q34801776-B3E0FECE-E927-4E28-8271-5978E1A6EE41

P31

Q34801776-B9ECDCE9-79BC-4D40-80C1-228E7D513787

P356

Q34801776-B84D1D75-B498-4439-BD68-9663A3EAD75E

P407

Q34801776-C30CA277-9C60-449E-B804-20965F399BAE

P433

Q34801776-D6157C1B-7633-4C07-BD80-11A390E1D542

P478

Q34801776-4179D11B-D783-4567-8B64-BCA4551F8C8C

P50

Q34801776-574489D8-9C09-4991-A078-23E622E5C58F

P577

Q34801776-9BC0FA26-9E5B-4E80-BF86-A9CEC8CF05DF

P5875

Q34801776-5A2756BF-880A-4781-96A4-0C24456276F9

P698

Q34801776-998E6EF5-5FB8-42AD-9A87-31A0FB5C772F

P921

Q34801776-E1EDE388-659E-48E7-ABBD-723D2A86C848

P932

Q34801776-87C68745-A128-469B-A34E-94F7A81DE71D

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Virus-specific immunity after ...... ere combined immunodeficiency.

@en

P2093

B P Sorrentino

http://www.w3.org/2001/XMLSchema#string

J M Riberdy

http://www.w3.org/2001/XMLSchema#string

K D Bunting

http://www.w3.org/2001/XMLSchema#string

K J Flynn

http://www.w3.org/2001/XMLSchema#string

P2860

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

Structural and functional basis for JAK3-deficient severe combined immunodeficiency

Phenotypic analysis of antigen-specific T lymphocytes

Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)

Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses

Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease

Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.

Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.

Antibody production and protection against influenza virus in immunodeficient mice.

Maximum-likelihood analysis of human T-cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency

P304

232-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.96.1.232

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

Peter C. Doherty

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13413257

http://www.w3.org/2001/XMLSchema#string

P698

9874801

http://www.w3.org/2001/XMLSchema#string

P921

P932

15122

http://www.w3.org/2001/XMLSchema#string